Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy
Clinical trial NCT04599556 · UNKNOWN
Trial details
- NCT number
- NCT04599556
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-12-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.